Statistics

Total Visits

Views
Lurbinectedin (PM01183) activity in BRCA1/2-associated or unselected metastatic breast cancer. Interim results of an ongoing phase II trial54

Select a period of time:

Number of views in the range

Views
Lurbinectedin (PM01183) activity in BRCA1/2-associated or unselected metastatic breast cancer. Interim results of an ongoing phase II trial29

Views

Views
December 20241
January 20252
February 20257
March 202515
April 20254
May 20250
June 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
United States11
Germany1
Spain1
United Kingdom1
 

Top cities views

Views
Council Bluffs1